Australian Clinical Labs Limited (ASX:ACL)

Australian Clinical Labs Revenue

Australian Clinical Labs had revenue of 365.39M AUD in the half year ending December 31, 2025, with 8.34% growth. This brings the company's revenue in the last twelve months to 737.49M, up 1.27% year-over-year. In the fiscal year ending June 30, 2025, Australian Clinical Labs had annual revenue of 741.27M with 6.45% growth.

• Revenue (ttm): 737.49M
• Revenue Growth: +1.27%
• P/S Ratio: 0.56
• Revenue / Employee: 156.91K
• Employees: 4,700
• Market Cap: 416.02M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	741.27M	44.90M	6.45%
Jun 30, 2024	696.37M	-704.00K	-0.10%
Jun 30, 2023	697.07M	-298.53M	-29.99%
Jun 30, 2022	995.60M	348.90M	53.95%
Jun 30, 2021	646.70M	156.13M	31.83%